Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Regulus Therapeutics Inc (NASDAQ:RGLS)

5.91
BATS BZX Real-Time Price
As of 9:42am ET
 +0.06 / +1.03%
Today’s Change
5.14
Today|||52-Week Range
21.22
-32.22%
Year-to-Date

Stock Price Forecast

The 4 analysts offering 12-month price forecasts for Regulus Therapeutics Inc have a median target of 27.50, with a high estimate of 42.00 and a low estimate of 15.00. The median estimate represents a +365.31% increase from the last price of 5.91.

Analyst Recommendations

The current consensus among 6 polled investment analysts is to Buy stock in Regulus Therapeutics Inc. This rating has held steady since January, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.25
Sales
$5.1M
Reporting Date
Feb 17

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 0.67%
 
 
 
 
 
 
Growthannually 7.49%
 
 
 
 
 

Sales

Growthquarterly 172.66%
 
 
 
 
 
 
Growthannually 95.18%
 
 
 
 
 
Key to the earnings and sales forecast charts.